Literature DB >> 30913110

Treatment Planning for Periimplant Mucositis and Periimplantitis.

Ioannis Polyzois1.   

Abstract

PURPOSE: A literature search was performed in a number of health care databases for articles published until January 2018. DISCUSSION: A number of anatomical factors, risk indicators, possible aesthetic complications, and financial implications have to be taken into consideration before treatment commences. When diagnosed early, periimplant mucositis is a problem that can be easily managed as long as the patient is motivated and maintains good levels of oral hygiene. Periimplantitis is more difficult to treat and results can be unpredictable. Nonsurgical therapy has limited effectiveness on the treatment of periimplantitis, but it should always precede a surgical intervention. Clinically predictable surgical outcomes seem to rely mainly on the configuration of the bone defect, the position of the affected implant, and the patient's ability to perform good oral hygiene.
CONCLUSIONS: Thorough treatment planning of periimplant diseases is paramount for the success of the treatment that follows. Local and general factors as well as patients' expectations have to be considered before proceeding, but treatment planning should also allow for a degree of flexibility, which will accommodate the unknown parameters.

Entities:  

Mesh:

Year:  2019        PMID: 30913110     DOI: 10.1097/ID.0000000000000869

Source DB:  PubMed          Journal:  Implant Dent        ISSN: 1056-6163            Impact factor:   2.454


  2 in total

1.  Diagnosis and non-surgical treatment of peri-implant diseases and maintenance care of patients with dental implants - Consensus report of working group 3.

Authors:  Stefan Renvert; Hideaki Hirooka; Ioannis Polyzois; Anastasia Kelekis-Cholakis; Hom-Lay Wang
Journal:  Int Dent J       Date:  2019-09       Impact factor: 2.607

2.  Long-Term Influence of Platelet-Rich Plasma (PRP) on Dental Implants after Maxillary Augmentation: Retrospective Clinical and Radiological Outcomes of a Randomized Controlled Clinical Trial.

Authors:  Sameh Attia; Clara Narberhaus; Heidrun Schaaf; Philipp Streckbein; Jörn Pons-Kühnemann; Christian Schmitt; Friedrich Wilhelm Neukam; Hans-Peter Howaldt; Sebastian Böttger
Journal:  J Clin Med       Date:  2020-01-28       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.